Daily OTC Pearl: MiraLAX (Polyethylene Glycol 3350)

Article

MiraLAX is used as a laxative to treat occasional constipation or irregular bowel movements.

OTC/Lifestyle Pearl of the Day: MiraLAX (Polyethylene Glycol 3350)

Indication: MiraLAX (polyethylene glycol 3350) is a laxative solution that increases the amount of water in the intestinal tract to stimulate bowel movements.

Sources:

  • MiraLAX is used as a laxative to treat occasional constipation or irregular bowel movements.
  • MiraLAX may also be used for purposes not listed in this medication guide.
  • You should not use MiraLAX if you have a bowel obstruction or intestinal blockage.
  • MiraLAX should produce a bowel movement within 1 to 3 days of using the medication. Polyethylene glycol 3350 normally causes loose or even watery stools.
  • FDA pregnancy category C. It is not known whether MiraLAX will harm an unborn baby. Tell your physician if you are pregnant or plan to become pregnant while using this medication.
  • Pour the powder into 4 to 8 ounces of a cold or hot beverage such as water, juice, soda, coffee, or tea. Stir this mixture and drink it right away. Do not save for later use.
  • MiraLAX should produce a bowel movement within 1 to 3 days of using the medication. Polyethylene glycol 3350 normally causes loose or even watery stools.
  • 17 g (diluted in 8 fluid ounces water, juice, soda or coffee) orally once a day.

Sources:

Related Videos
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Image credit: Fabio Balbi | stock.adobe.com
Image credit: Melita - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.